Assessment of the Budesonid Protective Effects in Patients with Cardio-Respiratory Comorbidity During Coronary Bypassing with Artificial Circulation

Assessment of the Budesonid Protective Effects in Patients with Cardio-Respiratory Comorbidity During Coronary Bypassing with Artificial Circulation

The objective: evaluation of the effect of budesonide and low-volume mechanical ventilation (LVMV) on pulmonary volemia, oxygen transport and respiratory biomechanics in patients with concurrent ischemic heart disease (IHD) and chronic obstructive pulmonary disease (COPD) during coronary artery bypa...

Full description

Bibliographic Details
Main Authors:	E. A. Sergeev, B. I. Geltser, V. N. Kotelnikov, A. E. Tarasov, V. Yu. Velichkin, A. A. Silaev
Format:	Article
Language:	Russian
Published:	New Terra Publishing House 2022-05-01
Series:	Вестник анестезиологии и реаниматологии
Subjects:	хроническая обструктивная болезнь легких коронарное шунтирование будесонид защита легких протективная искусственная вентиляция легких
Online Access:	https://www.vair-journal.com/jour/article/view/645

Similar Items

Кардиореспираторные послеоперационные осложнения у пациентов с ишемической болезнью сердца после планового коронарного шунтирования: связь с функцией легких
by: E. V. Bazdyrev, et al.
Published: (2017-07-01)

Eﬀect of the combination of theophylline and budesonide on production of proinﬂammatory cytokines by blood cells of patients with chronic obstructive pulmonary disease
by: A. G. Kadushkin, et al.
Published: (2021-11-01)

PERI-OPERATIVE PROTECTIVE ARTIFICIAL PULMONARY VENTILATION IN ABDOMEN SURGERY
by: D. B. Borisov, et al.
Published: (2018-01-01)

Mechanical Ventilation. Total Eclipse of the Heart (Editorial)
by: G. Landoni, et al.
Published: (2021-10-01)

Coronary artery status in patients with coronary heart disease and chronic obstructive pulmonary disease: results of selective coronary angiography
by: N. Yu. Grigorieva, et al.
Published: (2012-10-01)

Functional State of Respiratory Muscles in Patients with Chronic Obstructive Pulmonary Disease
by: I. G. Kurpаtov, et al.
Published: (2021-07-01)

AEROSOL THERAPY DURING NON-INVASIVE VENTILATION
by: S. N. Аvdeev
Published: (2018-05-01)

CHRONIC OBSTRUCTIVE PULMONARY DISEASE: DEFINITION, EPIDEMIOLOGY, PATHOPHYSIOLOGY, CLINICAL PICTURE AND TREATMENT (GOLD 2013)
by: M. T. Vatutin, et al.
Published: (2015-12-01)

The chronic obcructive pulmonary disease in military veterans: problems and perspectives
by: G I Gurko
Published: (2010-12-01)

Systemic cytokine potential in patients with chronic obstructive pulmonary disease who completed treatment for pulmonary tuberculosis
by: A. A. Khrenov, et al.
Published: (2020-02-01)

The importance of respiration biomechanics and high resolution computed tomography for bronchial-obstructive syndrome diagnostics
by: E. V. Ekkardt
Published: (2010-06-01)

Arteriovenous shunt fraction as a marker for early diagnosis of acute respiratory distress syndrome against the background of cardiogenic pulmonary edema: a case report
by: V. V. Kirilin, et al.
Published: (2022-03-01)

ROLE OF SYSTEMATIC INFLAMMATION IN THE DEVELOPMENT OF COMORBIDITY IN CASE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: V. A. Nikitin, et al.
Published: (2017-06-01)

Influence of COPD on the development of renal disease and identification of nature of kidney with specific markers
by: V V Trishina, et al.
Published: (2012-06-01)

COVID-19 and chronic obstructive pulmonary disease: what is known about the unknown
by: E. S. Ovsyannikov, et al.
Published: (2021-03-01)

Role of copd in the development of kidney pathology
by: V V Trishina, et al.
Published: (2011-06-01)

Approaches to the diagnosis, treatment and prevention of exacerbations of chronic obstructive pulmonary disease. According to the materials of the Congress «Chelovek I lekarstvo» and the Summit of pulmonologists-2019
by: Yu. V. Evsyutina
Published: (2019-12-01)

ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: E. I. Leonova, et al.
Published: (2015-09-01)

Eosinophils as a non-invasive marker to assess inflammatory activities in those suffering from chronic obstructive pulmonary disease
by: M. A. Kаrnаushkinа, et al.
Published: (2018-11-01)

The variation of respiration biomechanics and high resolution computed tomography indices when analyzing chronic obstructive lung disease
by: E. V. Ekkardt, et al.
Published: (2011-02-01)

СРАВНИТЕЛЬНЫЙ АНАЛИЗ УРОВНЯ ПРОВОСПАЛИТЕЛЬНЫХ ЦИТОКИНОВ У ПАЦИЕНТОВ С ХРОНИЧЕСКОЙ ОБ СТРУКТИВНОЙ БОЛЕЗНЬЮ ЛЕГКИХ в зависимости от стадии заболевания
by: Л. Ю. Долинина, et al.
Published: (2012-02-01)

Changes in the ventilation function of the lungs during the formation of chronic obstructive pulmonary disease and its combination with lung cancer
by: S. Yu. Dobner, et al.
Published: (2021-01-01)

FABRIC NON-ELASTIC PULMONARY RESISTANCE IN CASE OF BRONCHIAL ASTHMA AND GOLD: DISTINCTION AND CHANGES NATURE
by: T. S. Ageyeva, et al.
Published: (2013-12-01)

Outside of easy display of chronic obstructive pulmonary disease: clinical and functional-morphological aspects of changes of intestines
by: E. I. Beloborodova, et al.
Published: (2009-08-01)

Self-management of the disease and its role in preventing exacerbations in chronic obstructive pulmonary disease
by: L. V. Kukol, et al.
Published: (2020-03-01)

CHRONIC OBSTRUCTIVE LUNG DISEASE AS RISK FACTOR FOR CARDIOVASCULAR DISORDERS
by: A. V. Budnevsky, et al.
Published: (2016-06-01)

Energy metabolism regulators effect on clinical course and inflammatory markers in patients with exacerbation of severe copd
by: M. S. Sanzharovskaya, et al.
Published: (2008-09-01)

Dynamics of respiratory system clinicofunctional scores among patients with COPD in the complex rehabilitation at the Health resort Belokurikha
by: K. V. Komissarov, et al.
Published: (2010-12-01)

EFFECT OF BRONCHODILATORS ON HEART RATE VARIABILITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: H. H. Shugushev, et al.
Published: (2015-12-01)

Systemic inflammation and complications of”vascular" comorbidity in patients with COPD
by: A. S. Skotnikov, et al.
Published: (2015-10-01)

Budesonide in patients with obstructive pulmonary disease
by: N. N. Mescheryakova
Published: (2015-12-01)

Антибактериальная терапия инфекций дыхательных путей: практические рекомендации
Published: (2016-12-01)

Clinical, cardio-hemodynamical, and respiratory effects of ACE inhibitor cilazapril in patients with arterial hypertension and chronic obstructive pulmonary disease
by: L. I. Olbynskaya, et al.
Published: (2005-02-01)

COMPARATIVE ASSESSMENT OF RESPIRATORY MUSCLE STRENGTH IN THOSE WITH ASTHMA, CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND COMBINATION OF THESE TWO CONDITIONS
by: B. I. Geltser, et al.
Published: (2019-03-01)

NEUROGENIC PULMONARY EDEMA
by: V. I. Shatalov, et al.
Published: (2018-02-01)

Subpopulations of blood monocytes in patients with generalized hypoxia
by: S. P. Chumakova, et al.
Published: (2019-05-01)

EARLY DETECTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE — VECTOR ON BIOMARKERS
by: V. I. Shevcova, et al.
Published: (2016-08-01)

COMBINATION THERAPY WITH BISOPROLOL AND AMLODIPINE IN TREATMENT OF ARTERIAL HYPERTENSION PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: V. A. Nikitin, et al.
Published: (2015-08-01)

Functional state of the diaphragm in patients with chronic obstructive pulmonary disease on long-term oxygen therapy
by: O. N. Titova, et al.
Published: (2017-01-01)

THE ROLE OF MICROBIAL COMMUNITIES OF AIRWAYS IN PATHOGENESIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: S. V. Fedosenko, et al.
Published: (2014-02-01)